Orchestra BioMed Holdings Inc. (OBIO)
$5.35 -$0.15 (-2.67%) 4:38 PM 12/11/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$191.21M -
Day's Range
$5.21 - $5.75 -
Volume
56,921 -
52 Week Low / High
$4.22 - $11.69 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
OBIO's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 3
- Strong Buy
- 2
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $20.33
- Target Price
Company News
-
Orchestra BioMed Reports Second Quarter 2024 Financial Results and Provides a Business Update — Aug 12th, 2024
Orchestra BioMed Holdings, Inc. NEW HOPE, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partn...
Similar Stocks
No similar stocks found.
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$